the Japanese Society of Gastrointestinal Cancer Screening

日本肥満学会

Effects of 1-kestose on microbiome changes caused by vonoprazan: a randomized, double-blind, placebo-controlled pilot study Reviewed

Furune S, Suzuki T, Honda T, Yamamoto K, Furukawa K, Nakamura M, Ishigami M, Kinoshita F, Kadota Y, Tochio T, Shimomura Y, Hirooka Y, Fujishiro M, Kawashima H.

J Gastroenterol Hepatol   Vol. 39 ( 3 ) page： 480 - 488   2023.12

Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis Reviewed

Sugiyama Y, Yamamoto K, Honda T, Kato A, Muto H, Yokoyama S, Ito T, Imai N, Ishizu Y, Nakamura M, Asano T, Enomoto A, Zaitsu K, Ishigami M, Fujishiro M, Kawashima H.

Hepatol Internatoinal   Vol. 17 ( 6 ) page： 1378 - 1392   2023.9

Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study Reviewed

Ikegami S, Nakamura M, Honda T, Yamamura T, Maeda K, Sawada T, Ishikawa E, Yamamoto K, Furune S, Ishikawa T, Furukawa K, Ohno E, Ishigami M, Kinoshita F, Kadota Y, Tochio T, Shimomura Y, Hirooka Y, Kawashima H.

Aliment Pharmacol Ther   Vol. 57 ( 11 ) page： 1249 - 1257   2023.1

Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma Reviewed

Inukai Y, Yamamoto K, Honda T, Ito T, Imai N, Ishizu Y, Nakamura M, Kawashima H, Ishigami M.

  Vol. 41 ( 1 ) page： 138 - 147   2023

Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan Reviewed

Hamazaki M, Sawada T, Yamamura T, Maeda K, Mizutani Y, Ishikawa E, Furune S, Yamamoto K, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Nakamura M, Fujishiro M.

  Vol. 22 ( 1 ) page： 342 - -   2022.7

Changes in the gut microbiome in relation to the degree of gastric mucosal atrophy before and after Helicobacter pylori eradication Reviewed

Furune S, Yamamoto K, Honda T, Fujiyoshi T, Kakushima N, Furukawa K, Ohno E, Nakamura M, Miyahara R, Kawashima H, Ishigami M, Hirooka Y, Fujishiro M.

Scand J Gastroenterol   Vol. 57 ( 3 ) page： 266 - 273   2022.5

Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease Reviewed

Yamamoto K, Ishizu Y, Honda T, Ito T, Imai N, Nakamura M, Kawashima H, Kitaura Y, Ishigami M, Fujishiro M.

Sci Rep   Vol. 12 ( 1 ) page： 3674   2022.3

慢性肝疾患患者におけるサルコペニアと腸内細菌叢 Invited Reviewed

山本 健太, 石津 洋二, 本多 隆

Progress in Medicine   Vol. 42 ( 3 ) page： 233 - 238   2022.3

Preliminary Comparison of Endoscopic Brush and Net Catheters as the Sampling Tool to Analyze the Intestinal Mucus in the Rectum with Ulcerative Colitis Patients Reviewed

Nakamura M, Maeda K, Yamamoto K, Yamamura T, Sawada T, Ishikawa E, Kakushima N, Furukawa K, Iida T, Mizutani Y, Ishikawa T, Ohno E, Honda T, Ishigami M, Kawashima H.

Digestion   Vol. 103 ( 3 ) page： 232 - 243   2022.2

Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer Reviewed

Ohashi A, Yamamura T, Nakamura M, Maeda K, Sawada T, Ishikawa E, Yamamoto K, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Fujishiro M.

  Vol. 103 ( 6 ) page： 451 - 461   2022

Changes in the gut microbiota after hepatitis C virus eradication Reviewed

Honda T, Ishigami M, Yamamoto K, Takeyama T, Ito T, Ishizu Y, Kuzuya T, Nakamura M, Kawashima H, Miyahara R, Ishikawa T, Hirooka Y, Fujishiro M.

Sci Rep   Vol. 11 ( 1 ) page： 23568   2021.12

Measurement of fasting breath hydrogen concentration as a simple diagnostic method for pancreatic exocrine insufficiency Reviewed

Uetsuki K, Kawashima H, Ohno E, Ishikawa T, Iida T, Yamamoto K, Furukawa K, Nakamura M, Honda T, Ishigami M, Hirooka Y, Fujishiro M

BMC gastroenterology   Vol. 21 ( 1 ) page： 211   2021.5

Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine Reviewed

Kenta Yamamoto Takashi Honda Shinya Yokoyama Lingyun Asuka Kato Takanori Ito Yoji Ishizu Teiji Kuzuya Masanao Nakamura Hiroki Kawashima Masatoshi Ishigami Noriko M.Tsuji Mitsuhiro Fujishiro

Digestive and Liver Disease   Vol. 53 ( 11 ) page： 1443 - 1450   2021

Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis. Reviewed

Muto H, Ito T, Tanaka T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Maeda K, Honda T, Ishikawa T, Kato A, Ohshiro T, Kano F, Yamamoto A, Sakai K, Hibi H, Ishigami M, Fujishiro M

Scientific reports.   Vol. 11 ( 1 ) page： 18778   2021

The microbiome can predict mucosal healing in small intestine in patients with Crohn’s disease Reviewed

Shun Hattori, Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Yasuyuki Mizutani, Kenta Yamamoto, Takuya Ishikawa, Kazuhiro Furukawa, Eizaburo Ohno, Takashi Honda, Hiroki Kawashima, Masatoshi Ishigami, Yoshiki Hirooka Mitsuhiro Fujishiro

Journal of gastroenterology   Vol. 55 ( 12 ) page： 1138 - 1149   2020.12

The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis C Reviewed

Kenta Yamamoto , Takashi Honda , Takanori Ito , Yoji Ishizu , Teiji Kuzuya , Masanao Nakamura , Ryoji Miyahara , Hiroki Kawashima , Masatoshi Ishigami , Mitsuhiro Fujishiro

Journal of Gastroenterology and Hepatology   Vol. 36 ( 3 ) page： 790 - 799   2020.8

Relationship between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Reviewed

Yamamoto, Kenta, Teiji Kuzuya, Takashi Honda, Takanori Ito, Yoji Ishizu, Masanao Nakamura, Ryoji Miyahara, Hiroki Kawashima, Masatoshi Ishigami, and Mitsuhiro Fujishiro

Anticancer Research   Vol. 40 ( 2 ) page： 665–76   2020

Microbiota Profile Is Different for Early and Invasive Colorectal Cancer and Is Consistent throughout the Colon. Reviewed

Zorron Cheng Tao Pu, Leonardo, Kenta Yamamoto, Takashi Honda, Masanao Nakamura, Takeshi Yamamura, Shun Hattori, Alastair D. Burt, Rajvinder Singh, Yoshiki Hirooka, and Mitsuhiro Fujishiro.

Journal of Gastroenterology and Hepatology   Vol. 35 ( 3 ) page： 433–37   2020

Influence of Proton Pump Inhibitors on Microbiota in Chronic Liver Disease Patients. Reviewed

Yamamoto, Kenta, Masatoshi Ishigami, Takashi Honda, Tomoaki Takeyama, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Hidemi Goto, and Yoshiki Hirooka.

Hepatology International   Vol. 13 ( 2 ) page： 234–44   2019

Impact of BMI and Body Composition on First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma Reviewed

Yamamoto T, Ito T, Mizuno K, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H.

Anticancer Res   Vol. 44 ( 9 ) page： 4101 - 4111   2024.8

Predicting early rebleeding and mortality after endoscopic hemostasis of esophagogastric varices: Diagnostic performance of aspartate aminotransferase-to-platelet ratio index and model for end-stage liver disease-Na score Reviewed

Yokoyama S, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Mizuno K, Nakamura M, Kawashima H.

J Hepatobiliary Pancreat Sci     2024.7

Clinical Outcomes of Use of the Porous Glass Membrane Pumping Emulsification Device During Transarterial Chemoembolization for Hepatocellular Carcinoma Reviewed

Mizuno F, Imai N, Mizuno K, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kawashima H.

Anticancer Res   Vol. 44 ( 7 ) page： 3185 - 3191   2024.6

Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center Reviewed

Yokoyama S, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Mizuno K, Kojima T, Kariya N, Nakamura M, Kawashima H.

Clin Nutr   Vol. 43 ( 6 ) page： 1425 - 1432   2024.5

Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team Reviewed

Ito T, Mizuno K, Yamamoto T, Yasuda T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Hama M, Kataoka T, Shimokata T, Ando Y, Kawashima H.

Hepatol Res     2024.4

A new criterion including the aspartate aminotransferase-to-platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria Reviewed

Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Muto H, Shirota C, Tainaka T, Sumida W, Makita S, Takada S, Nakagawa Y, Maeda T, Nakamura M, Ishigami M, Uchida H, Kawashima H.

Hepatol Res     2023.10

Clinical course and prognosis of patients with hepatocellular carcinoma and haemophilia Reviewed

Matsuda N, Imai N, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Kawashima H.

European Journal of Gastroenterology and Hepatology   Vol. 35 ( 10 ) page： 1211 - 1215   2023.8

Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma Reviewed

Mizuno K, Imai N, Yamamoto T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kuzuya T, Ishigami M, Kawashima H.

Cancers   Vol. 21 ( 15 ) page： 2853   2023.6

Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis Reviewed

Yamamoto T, Mizuno K, Ito T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Ishikawa T, Kanamori A, Yasuda S, Toyoda H, Yokota K, Hase T, Nishio N, Maeda O, Ishii M, Sone M, Ando Y, Akiyama M, Ishigami M, Kawashima H.

Investigational New Drugs   Vol. 41 ( 3 ) page： 512 - 521   2023.5

Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis Reviewed

Mizuno F, Imai N, Yasuda K, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M, Kawashima H.

Internal Medicine     2023.5

Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases Reviewed

Imai N, Ohsaki Y, Cheng J, Zhang J, Mizuno F, Tanaka T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M, Wake H, Kawashima H.

Scientific Reports   Vol. 26 ( 13 ) page： 6851   2023.4

腹部領域の技術と臨床の最新動向　放射線治療におけるMRI-US Fusion技術を活用した金マーカー留置の実際 Invited

山本　健太

INNERVISION   Vol. 38 ( 5 ) page： 50 - 53   2023.4

Proteomic Analysis Reveals Changes in Tight Junctions in the Small Intestinal Epithelium of Mice Fed a High-Fat Diet Reviewed

Muto H, Honda T, Tanaka T, Yokoyama S, Yamamoto K, Ito T, Imai N, Ishizu Y, Maeda K, Ishikawa T, Adachi S, Sato C, Tsuji NM, Ishigami M, Fujishiro M, Kawashima H.

Nutrients   Vol. 19 ( 15 ) page： 1473   2023.3

Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury Reviewed

Yamamoto T, Morooka H, Ito T, Ishigami M, Mizuno K, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Yokota K, Hase T, Maeda O, Hashimoto N, Ando Y, Akiyama M, Kawashima H.

  Vol. 38 ( 2 ) page： 251 - 258   2023.2

Endoscopic injection sclerotherapy with polidocanol for cardiac varices in children and adolescents Reviewed

Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Hinoki A, Sumida W, Shirota C, Tainaka T, Makita S, Yokota K, Uchida H, Ishigami M.

  Vol. 30 ( 2 ) page： 109 - 112   2023.2

Significance of pretreatment alpha-fetoprotein in patients with compensated severe fibrosis after hepatitis C viral eradication Reviewed

Ishigami M, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Kawashima H.

J Hepatobiliary Pancreat Sci   Vol. 30 ( 6 ) page： 834 - 842   2023.1

Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet Reviewed

Zhao M, Ma L, Honda T, Kato A, Ohshiro T, Yokoyama S, Yamamoto K, Ito T, Imai N, Ishizu Y, Nakamura M, Kawashima H, Tsuji NM, Ishigami M, Fujishiro M.

  Vol. 68 ( 1 ) page： 155 - 163   2023.1

The presence of high-risk varices after sclerotherapy in biliary atresia Reviewed

Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Shirota C, Tainaka T, Sumida W, Makita S, Takimoto A, Nakagawa Y, Takada S, Ishigami M, Uchida H, Kawashima H.

Pediatr Int   Vol. - ( - ) page： - - -   2022.12

Pipeline Esophagogastric Varices Secondary to Extrahepatic Portal Vein Obstruction Treated Endoscopically with the Assistance of Transileocolic Obliteration Reviewed

Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Komada T, Hayashi M, Ishigami M.

  Vol. 61 ( 23 ) page： 3503 - 3511   2022.12

An improved method to assess skeletal muscle mass in patients with liver cirrhosis based on computed tomography images Reviewed

Sugiyama Y, Ishizu Y, Ando Y, Yokoyama S, Yamamoto K, Ito T, Imai N, Nakamura M, Honda T, Kawashima H, Ishikawa T, Ishigami M.

  Vol. 52 ( 11 ) page： 937 - 946   2022.11

Effect of illness uncertainty on alanine transaminase levels and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease Reviewed

Ozawa N, Sato K, Sugimura A, Maki S, Tanaka T, Yamamoto K, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishigami M, Fujishiro M, Ishikawa T, Ando S.

  Vol. 84 ( 4 ) page： 857 - 864   2022.11

Decreased appetite is associated with the presence of sarcopenia in patients with cirrhosis Reviewed

Ishizu Y, Ishigami M, Honda T, Imai N, Ito T, Yamamoto K, Yokoyama S, Ishikawa T, Kawashima H.

Nutrition   Vol. - ( - ) page： - - -   2022.11

Factors associated with the progression of myosteatosis in patients with cirrhosis Reviewed

Ishizu Y, Ishigami M, Honda T, Imai N, Ito T, Yamamoto K, Yokoyama S, Ishikawa T, Fujishiro M.

Nutrition   Vol. - ( - ) page： - - -   2022.11

Effectiveness of Porous Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Solitary Hepatocellular Carcinoma Reviewed

Imai N, Ishigami M, Oie Y, Kumagai M, Inukai Y, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kawashima H.

  Vol. 42 ( 8 ) page： 3947 - 3951   2022.8

A case of antiprogrammed death-ligand 1 antibody-induced multisystem immune-related adverse events with pancreatitis and steroid-resistant sclerosing cholangitis Reviewed

Yamamoto T, Ito T, Mizuno K, Shinya Y, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H, Matsui T, Hase T, Hashimoto N, Ishigami M.

  Vol. 23 ( 7 ) page： 404 - 409   2022.7

Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study Reviewed

Yamamoto T, Imai N, Kuzuya T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M.

Nutr Cancer   Vol. 74 ( 9 ) page： 3118 - 3127   2022.3

Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors Reviewed

Yamamoto T, Ito T, Hase T, Ishigami M, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Shibata H, Hatta T, Yogo N, Yasuda S, Toyoda H, Abe T, Kawashima H, Hashimoto N, Fujishiro M.

  Vol. 40 ( 2 ) page： 189 - 198   2022.2

Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis Reviewed

Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Tsuzuki T, Ishigami M.

  Vol. 52 ( 2 ) page： 199 - 209   2022.2

Obesity and myosteatosis: the two characteristics of dynapenia in patients with cirrhosis Reviewed

Sugiyama Y, Ishizu Y, Ando Y, Yokoyama S, Yamamoto K, Ito T, Imai N, Nakamura M, Honda T, Kawashima H, Ishikawa T, Ishigami M.

Eur J Gastroenterol Hepatol   Vol. 33 ( S1 ) page： :e916 - e921   2021.12

Safety and Efficacy of Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Hepatocellular Carcinoma: First Clinical Outcomes. Reviewed

Norihiro Imai, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami

Anticancer research   Vol. 41 ( 11 ) page： 5817 - 5820   2021.11

Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis Reviewed

Shinya Yokoyama, Yoji Ishizu 1, Takashi Honda, Norihiro Imai, Takanori Ito, Kenta Yamamoto, Tomoyuki Tsuzuki, Masatoshi Ishigami

Hepatology research   Vol. 52 ( 2 ) page： 199 - 209   2021.10

Immune-related liver injury is a poor prognostic factor in patients with non-small cell lung cancer treated with immune checkpoint inhibitors Reviewed

Takafumi Yamamoto, Takanori Ito, Tetsunari Hase, Masatoshi Ishigami, Kazuyuki Mizuno, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Hirofumi Shibata, Takahiro Hatta, Naoyuki Yogo, Satoshi Yasuda, Hidenori Toyoda, Takashi Abe, Hiroki Kawashima, Naozumi Hashimoto, Mitsuhiro Fujishiro

Cancer investigation     2021.10

The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia: HCC after HCV eradication in hemophilia. Reviewed

Inukai Y, Imai N, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Fujishiro M

Annals of hepatology     2021.9

Revisiting Prognosis After Liver Transplant in Patients Positive for Hepatitis C Virus: Focus on Hepatitis C Recurrence-Unrelated Complications. Reviewed

Ishigami M, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Kamei H, Ogura Y, Fujishiro M

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation   Vol. 19 ( 9 ) page： 935 - 942   2021.9

Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies Reviewed

Ito T, Ishigami M, Yamamoto T, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H, Yasuda S, Toyoda H, Yokota K, Hase T, Nishio N, Maeda O, Kato M, Hashimoto N, Hibi H, Kodera Y, Sone M, Ando Y, Akiyama M, Shimoyama Y, Fujishiro M

Hepatology international   Vol. 15 ( 5 ) page： 1278 - 1287   2021.8

Quality of Life in patients with nonalcoholic fatty liver disease: Structure and related factors focusing on illness uncertainty. Reviewed

Naoki Ozawa Kazuki Sato Ayumi Sugimura Shigeyoshi Maki Taku Tanaka Kenta Yamamoto Takanori Ito Yoji Ishizu Teiji Kuzuya Takashi Honda Masatoshi Ishigami Mitsuhiro Fujishiro Tetsuya Ishikawa Shoko Ando

Japan journal of nursing science     2021.3

Progression After Molecular Targeted Agents: Hepatic Arterial Changes and Transarterial Chemoembolization in Hepatocellular Carcinoma Reviewed

NORITAKA MATSUDA, NORIHIRO IMAI, TEIJI KUZUYA, KENTA YAMAMOTO, TAKANORI ITO, YOJI ISHIZU, TAKASHI HONDA, MASATOSHI ISHIGAMI and MITSUHIRO FUJISHIRO

In vivo.   Vol. 35 ( 2 ) page： 1185 - 1189   2021.3

Impact of visceral fat accumulation on the prognosis of patients with cirrhosis Reviewed

Yoji Ishizu Masatoshi Ishigami Takashi Honda Norihiro Imai Takanori Ito Kenta Yamamoto Mitsuhiro Fujishiro

Clinical Nutrition ESPEN     2021.1

Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma patients with haemophilia Reviewed

Takafumi Yamamoto Norihiro Imai Kenta Yamamoto Takanori Ito Yoji Ishizu Takashi Honda Shuichi Okamoto Takeshi Kanematsu Nobuaki Suzuki Tadashi Matsushita Masatoshi Ishigami Mitsuhiro Fujishiro

Haemophilia   Vol. 27 ( 1 ) page： 100 - 107   2021.1

Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs Reviewed

Yamamoto T, Imai N, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Fujishiro M.

Anticancer research   Vol. 40 ( 5 ) page： 2569 - 2573   2021

The albumin-bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC Reviewed

Ito T, Ishigami M, Morooka H, Yamamoto K, Imai N, Ishizu Y, Honda T,Nishimura D, Tada T, Yasuda S, Toyoda H, Kumada T, Fujishiro

Scientific reports.   Vol. 10 ( 1 ) page： 17812   2020.10

Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.

Ma, Lingyun, Masatoshi Ishigami, Takashi Honda, Shinya Yokoyama, Kenta Yamamoto, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Yoshiki Hirooka, and Hidemi Goto.

Digestive Diseases and Sciences   Vol. 64 ( 9 ) page： 2581–90   2019

この症例に学ぶ　体外式腹部超音波検査にて描出しえた早期胃癌の一例 Invited Reviewed

山本 健太, 熊田 卓, 久永 康宏, 金森 明, 多田 俊史, 北畠 秀介, 曽根 康博

日本消化器がん検診学会雑誌   Vol. 52 ( 3 ) page： 387-392   2014.5

術中色素動注法が切除範囲決定に有用であった小腸angioectasiaの1例(原著論文/症例報告) Reviewed

山本 健太, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 多田 俊史, 北畠 秀介, 曽根 康博

日本消化器病学会雑誌   Vol. 111 ( 4 ) page： 773-778   2014.4

肝細胞癌と鑑別が困難であったreactive lymphoid hyperplasiaの1例 Reviewed

山本 健太, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 多田 俊史, 北畠 秀介, 長谷川 綾平, 伊藤 隆徳, 安藤 祐資, 颯田 祐介, 田中 達也, 曽根 康博, 福里 利夫

肝臓   Vol. 54 ( 11 ) page： 755-764   2013.11

腹腔鏡下胆嚢摘出術後13年目に生じた金属クリップを核とした胆管結石の1例 Reviewed

山本 健太, 金森 明, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 多田 俊史, 安東 直人, 新家 卓郎, 坂井 圭介, 安田 諭, 安藤 祐資, 木村 純, 曽根 康博, 熊田 卓

日本消化器内視鏡学会雑誌   Vol. 55 ( 5 ) page： 1667-1672   2013.5

Oral supplementation with branched-chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: A propensity score analysis Reviewed

Toshifumi Tada Takashi Kumada Hidenori Toyoda Seiki Kiriyama Makoto Tanikawa Yasuhiro Hisanaga Akira Kanamori Shusuke Kitabatake Takuro Niinomi Takanori Ito Ryohei Hasegawa Yusuke Ando Kenta Yamamoto Tatsuya Tanaka

Hepatology research   Vol. 44 ( 3 ) page： 288 - 295   2013.4

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients Reviewed

Kumada T, Toyoda H, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Niinomi T, Yasuda S, Andou Y, Yamamoto K, Tanaka J

Journal of Hepatology   Vol. 58 ( 3 ) page： 427-33   2013

肝切除を基本とした肝細胞癌の治療戦略 Invited Reviewed

多田 俊史, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 新家 卓郎, 長谷川 綾平, 伊藤 隆徳, 安田 諭, 安藤 祐資, 山本 健太, 田中 達也

消化器内科   Vol. 55 ( 5 ) page： 612-616   2012.11

この画像から何が読めるか?　肝腫瘤(図説) Invited Reviewed

山本 健太, 熊田 卓, 豊田 秀徳, 多田 俊史

肝胆膵画像   Vol. 14 ( 6 ) page： 542-545   2012.9

B型肝炎に対する核酸アナログ投与例の長期予後 Invited Reviewed

多田 俊史, 熊田 卓, 桐山 勢生, 谷川 誠, 豊田 秀徳, 久永 康宏, 金森 明, 新家 卓郎, 安東 直人, 坂井 圭介, 安田 諭, 木村 純, 安藤 祐資, 山本 健太

消化器内科   Vol. 54 ( 5 ) page： 608-613   2012.5

FOLFIRI+Panitumumab療法中に発症した薬剤性肺障害に対してステロイド・パルス療法が奏効したS状結腸癌の1例 Reviewed

山本 健太, 加藤 俊夫, 進藤 丈, 安藤 守秀, 安部 崇, 白木 晶, 中島 治典, 雪田 洋介

癌と化学療法   Vol. 53 ( 3 ) page： 326-330   2011.9

肝発癌を視野に入れたB型肝炎の治療戦略 Invited Reviewed

坂井 圭介, 熊田 卓, 豊田 秀徳, 桐山 勢生, 谷川 誠, 久永 康宏, 金森 明, 多田 俊史, 新家 卓郎, 安東 直人, 安田 諭, 安藤 祐資, 山本 健太, 木村 純

消化器内科   Vol. 53 ( 3 ) page： 326-330   2011.9

特異な形態を示し経カテーテル的動脈塞栓術を施行した膵十二指腸動脈瘤破裂の1例 Reviewed

山本 健太, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 多田 俊史, 荒川 恭宏, 藤森 将志, 新家 卓郎, 安東 直人

胆道   Vol. 24 ( 4 ) page： 603-610   2010.10

コイン型リチウム電池誤飲により食道潰瘍を来した2例　後遺症を残さなかった1例と後遺症を残した1例 Reviewed

山本 健太, 岩田 晶子, 都間 佑介, 田中 龍一, 山本 崇裕, 永田 智子, 伊藤 貴美子, 鹿野 博明, 中嶋 義記, 近藤 富雄

小児科臨床   Vol. 63 ( 7 ) page： 1667-1673   2010.7

造影超音波検査で特徴的な所見が得られた肝細胞腺腫の1例 Reviewed

山本 健太, 熊田 卓, 桐山 勢生, 曽根 康博, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 渥美 裕之, 高木 万起子, 中野 聡, 荒川 恭宏, 藤森 将志, 高橋 健一, 竹島 賢治, 乙部 克彦

肝胆膵画像   Vol. 11 ( 5 ) page： 564-570   2009.9

最新の超音波技術を用いた肝癌治療支援　体幹部定位放射線治療における金マーカー留置における超音波の活用

山本 健太, 石津 洋二, 伊藤 隆徳, 宜保 憲明, 飯田 忠, 水谷 泰之, 山雄 健太郎, 石川 卓哉, 川嶋 啓揮

日本超音波医学総会  2023.5.27 

肝線維化研究の最前線と治療への展開　ネットワーク解析を用いた線維化マーカーと腸内細菌叢の関係性の解明

山本 健太, 本多 隆, 石上 雅敏

日本消化器病学会総会  2023.4.6 

切除・穿刺局所療法が困難な4cm未満の単発肝細胞癌に関する定位放射線治療効果と肝予備能の変化

山本 健太, 石津 洋二, 水野 史崇, 松田 宜賢, 山本 崇文, 犬飼 庸介, 水野 和幸, 武藤 久哲, 横山 晋也, 伊藤 隆徳, 今井 則博, 本多 隆, 石上 雅敏, 川嶋 啓揮

日本消化器病学会総会  2023.4.6 

肝癌放射線治療におけるMRI-US fusionを用いた金マーカー留置術の正確性に関する検討

山本 健太, 石津 洋二, 伊藤 隆徳, 宜保 憲明, 山田 健太, 飯田 忠, 水谷 泰之, 石川 卓哉, 大野 栄三郎, 川嶋 啓揮

日本超音波医学会総会  2022.5.20 

マイクロバイオーム解析による消化器疾患の病態解明と応用　慢性肝疾患患者における腸内細菌ネットワーク解析と臨床的指標の関連性

山本 健太, 本多 隆, 石上 雅敏

日本消化器病学会総会  2022.4.21 

限局性肝癌に対する動体追尾定位放射線治療に必要な経皮経肝的マーカー留置術におけるMRI Fusion imagingの有用性

山本 健太, 松田 宜賢, 犬飼 庸介, 山本 崇文, 杉山 由晃, 吉岡 直輝, 水野 和幸, 武藤 久哲, 横山 晋也, 伊藤 隆徳, 今井 則博, 石津 洋二, 本多 隆, 石上 雅敏

日本消化器病学会総会  2022.4.21 

肝胆膵疾患診断・治療の最前線　限局性肝癌に対するサイバーナイフを用いた動体追尾定位放射線治療経験

山本 健太, 本多 隆, 石上 雅敏

日本消化器病学会東海地方会  2021.12.11 

生活習慣病・メタボリックシンドロームからの消化器疾患　次世代シーケンサーを用いた慢性肝疾患患者の腸内細菌叢と肥満・栄養に関する検討

山本 健太, 廣岡 芳樹, 後藤 秀実

日本消化器病学会  2017.3 

慢性肝疾患患者における生活習慣による腸内細菌への影響

山本 健太, 石上 雅敏, 田中 卓, 安藤 祐資, 伊藤 隆徳, 安田 諭, 野村 彩, 加藤 幸一郎, 石津 洋二, 葛谷 貞二, 本多 隆, 林 和彦, 廣岡 芳樹, 石川 哲也, 後藤 秀実

肝臓学会  2017.4 

初回治療TACEを施行した高齢患者における予後の検討

山本 健太, 石上 雅敏, 武藤 久哲, 横山 晋也, 田中 卓, 安藤 祐資, 伊藤 隆徳, 安田 諭, 石津 洋二, 葛谷 貞二, 本多 隆, 林 和彦, 廣岡 芳樹, 後藤 秀実

肝臓学会  2018.4 

Attenuation Imagingに対する級内相関係数を用いた検者内信頼性の検討

山本 健太, 石上 雅敏, 本多 隆, 葛谷 貞二, 石津 洋二, 廣岡 芳樹, 川嶋 啓揮, 中村 正直, 大野 栄三郎, 後藤 秀実

日本超音波医学会  2018.4 

次世代シーケンサーを用いた慢性肝疾患患者における腸内細菌の多様性を変化させる因子の検討

山本 健太, 本多 隆, 安藤 祐資, 田中 卓, 横山 晋也, 石津 洋二, 葛谷 貞二, 林 和彦, 石上 雅敏, 後藤 秀実

JDDW  2017.9 

肝線維化:診断・治療の基礎と臨床　C型肝炎患者におけるFib4 indexを用いた線維化度と腸内細菌叢に関する検討

山本 健太, 廣岡 芳樹, 後藤 秀実

日本消化器病学会  2018.3 

消化管疾患と肝疾患の関連-消化管・肝臓間の相互の影響-　Child-Pugh分類AもしくはBの慢性肝疾患患者におけるProton pump inhibitor使用による腸内細菌叢の比較

山本 健太, 石上 雅敏, 廣岡 芳樹

JDDW  2018.9 

肝疾患における臓器連関の役割　ランダムフォレストを用いた慢性肝疾患患者における筋肉量減少と関連ある腸内細菌叢の同定への試み

山本 健太, 本多 隆, 石上 雅敏

肝臓学会西部会  2021.11 

腸内細菌と肝疾患　慢性肝疾患患者における筋肉量、血清分岐鎖アミノ酸濃度、細菌叢の相関に関する検討

山本 健太, 本多 隆, 藤城 光弘

JDDW  2021.9 

消化吸収と臓器相関　慢性肝疾患患者における生活習慣・排便状況調査と腸内細菌叢に与える影響

山本 健太, 本多 隆, 藤城 光弘

日本消化器病学会  2021.3 

肝硬変による入院イベントと腸内細菌叢の関連性

山本 健太, 本多 隆, 山本 崇文, 犬飼 庸介, 杉山 由晃, 吉岡 直輝, 水野 和幸, 武藤 久哲, 横山 晋也, 伊藤 隆徳, 今井 則博, 石津 洋二, 石上 雅敏, 藤城 光弘

肝臓学会  2021.4 

慢性肝疾患患者における筋肉量減少と腸内細菌叢及び細菌叢が行うアミノ酸代謝に関する検討

山本 健太, 本多 隆, 山本 崇文, 犬飼 庸介, 杉山 由晃, 吉岡 直輝, 水野 和幸, 武藤 久哲, 横山 晋也, 田中 卓, 伊藤 隆徳, 石津 洋二, 葛谷 貞二, 石上 雅敏, 藤城 光弘

JDDW  2020.9 

肝疾患におけるバイオマーカー研究　慢性肝疾患患者における腸内細菌のPredicted Functional Dysbiosisに影響を与える因子についての検討

山本 健太, 本多 隆, 石上 雅敏

肝臓学会  2020.4 

進行肝細胞癌に対するソラフェニブ治療における有害事象及び治療効果と腸内細菌叢の検討

山本 健太, 葛谷 貞二, 本多 隆, 杉山 由晃, 吉岡 直輝, 水野 和幸, 武藤 久哲, 横山 晋也, 田中 卓, 伊藤 隆徳, 石津 洋二, 石上 雅敏, 藤城 光弘

肝臓学会西部会  2019.11 

ジエチルニトロサミンを用いたコリン欠乏高脂肪食によるNASHマウスモデルにおける発癌の検討

山本 健太, 本多 隆, 水野 和幸, 武藤 久哲, 横山 晋也, 田中 卓, 安藤 祐資, 伊藤 隆徳, 石津 洋二, 葛谷 貞二, 石井 雅敏, 廣岡 芳樹

日本消化器病学会  2019.3 

門脈圧亢進症診療の新しい潮流　門脈圧亢進症における腸内細菌叢の検討

山本 健太, 石上 雅敏, 廣岡 芳樹

日本消化器病学会  2019.3 

次世代シークエンサを用いたウイルスゲノム・マイクロバイオーム・エクソゾーム解析による肝疾患研究　血小板数とC型肝炎患者における腸内細菌叢及び予測機能遺伝子に関する検討

山本 健太, 本多 隆, 石上 雅敏

肝臓学会西部会  2018.11 

INVESTIGATING THE RELATIONSHIP BETWEEN GUT MICROBIOME AND FIBROSIS MARKERS IN PATIENTS WITH VIRAL HEPATITIS International conference

K. Yamamoto, T. Honda, Y. Inukai, S. Yokoyama, T. Ito, N. Imai, Y. Ishizu, H. Kawashima, M. Ishigami

United European Gastroenterology Week 2023  2023.10.14 

The Effect of Elobixibat on Tumorigenesis in the NASH Mice Model International conference

Kenta Yamamoto, Yoshiaki Sugiyama, Takashi Honda, Asuka Kato, Hisanori Muto, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masatoshi Ishigami, Hiroki Kawashima.

The Asian Pacific Association for the Study of the Liver single topic conference  2022.9.1 

Understanding the role of the microbiome in inflammatory diseases Invited International conference

Kenta Yamamoto, Anne-​Kathrin Classen

The Friburg univercity Rising Stars Conference  2022.3.23 

Correlation Between Gut Microbiota and Clinical Parameters in Patients with Alcoholic Liver Disease International conference

Kenta Yamamoto, Takashi Honda, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masatoshi Ishigami, Tetsuya Ishikawa, Hiroki Kawashima

The 3rd JSH International Liver Conference  2023.9.7 

Focusing on the oral origin bacteria in the gut Invited International coauthorship International conference

Kenta Yamamoto

United European Gastroenterology Week 2021  2021.10.4